The Law Offices of Frank R. Cruz announces an investigation of Profound Medical Corp. (“Profound” or the “Company”) (NASDAQ: PROF) on behalf of investors concerning the Company’s possible violations of federal securities laws.

What Is The Investigation About?
On March 7, 2025, Profound disclosed that it had “identified an error which overstated revenue by $472,000 in the first quarter of 2024.” The Company stated correction of this error “reduced revenue previously presented . . . in the first quarter, and in the year-to-date figures in the second and third quarters of 2024.” The Company advised that the affected financial statements “should no longer be relied upon as a result of the foregoing error.”

On this news, Profound’s stock price fell $0.43, or 5.9%, to close at $6.86 per share on March 7, 2025, thereby injuring investors.